Flutamide for Prostate Cancer
Phase-Based Progress Estimates
Effectiveness
Safety
Prostate Cancer
Flutamide - DrugEligibility
18+
Male
What conditions do you have?
Select
Eligibility
18+
Male
What conditions do you have?
Select
Study Summary
This trial will test if flutamide can help treat prostate cancer by creating double strand breaks in the DNA of cancer cells.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 6-9 months
6-9 months
time to DNA double strand break
Trial Safety
Safety Progress
Side Effects for
Flutamide
38%headache
31%stomach pain
23%dry skin
15%insomnia
15%nausea
15%hot flushes
15%Diarrhea
8%parasthesia
8%dry mouth
8%leg pain
8%fatigue
Trial Design
2 Treatment Groups
flutamide
1 of 2
placebo
1 of 2
Experimental Treatment
Non-Treatment Group
24 Total Participants · 2 Treatment Groups
Primary Treatment: Flutamide · Has Placebo Group · Phase < 1
flutamide
Drug
Experimental Group · 1 Intervention: Flutamide · Intervention Types: Drugplacebo
Other
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: OtherTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Flutamide
FDA approved
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6-9 months
Who is running the clinical trial?
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
534 Previous Clinical Trials
31,088 Total Patients Enrolled
51 Trials studying Prostate Cancer
2,961 Patients Enrolled for Prostate Cancer
Daniel Song, M.D.Principal InvestigatorSKCCC at Johns Hopkins
Eligibility Criteria
Age 18+ · Male Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:At least one biopsy core with Gleason 7 or higher disease.
Clinically palpable disease corresponding to (ipsilateral to) any involved core on biopsy.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments